Clinical Trial Update: Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating perampanel monotherapy for partial onset seizures has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-onset Seizures

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Partial Onset Seizures | Phase 3 | Status: COMPLETED | Results posted: 2020-02-25